Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract
mBio · 2024
DOI: 10.1128/mbio.02203-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Mila B Ortigoza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Orthomyxoviridae, Influenza A virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Influenza virus transmission studies have historically focused on viral mutations that alter hemagglutinin binding to sialic acid (SA) receptors in vitro . However, SA binding preference does not fully account for the complexities of influenza A virus transmission in humans. Our previous findings reveal that viruses that are known to bind α2,6-SA in vitro have different transmission kinetics in vivo , suggesting that diverse SA interactions may occur during their life cycle. In this study, we examine the role of host SA on viral replication, shedding, and transmission in vivo . We highlight the critical role of SA presence during virus shedding, such that attachment to SA during virion egress is equally important as detachment from SA during virion release. These insights support the potential of broadly acting neuraminidases as therapeutic agents capable of restraining viral transmission in vivo . Our study unveils intricate virus-host interactions during shedding, highlighting the necessity to develop innovative strategies to effectively target transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, New York, USA.
- Department of Microbiology, New York University School of Medicine, New York, New York, USA.
- Department of Pathology, New York University School of Medicine, New York, New York, USA.
ORCID-Profile: Mila B Ortigoza, Catherina L Mobini, Hedy L Rocha, Stacey Bartlett, Cynthia A Loomis, Jeffrey N Weiser
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Cancer Institute
- HHS | NIH | NIH Office of the Director
Zitieren
APA
Ortigoza, M. B., Mobini, C. L., Rocha, H. L., Bartlett, S., Loomis, C. A., & Weiser, J. N. (2024). Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract. mBio. https://doi.org/10.1128/mbio.02203-23
Vancouver
Ortigoza MB, Mobini CL, Rocha HL, Bartlett S, Loomis CA, Weiser JN. Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract. mBio. 2024. doi:10.1128/mbio.02203-23
BibTeX
@article{Ortigoza2024,
author = {Ortigoza, Mila B and Mobini, Catherina L and Rocha, Hedy L and Bartlett, Stacey and Loomis, Cynthia A and Weiser, Jeffrey N},
title = {Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.02203-23}
}
EUVIMED